Zurcher Kantonalbank (Zurich Cantonalbank) - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 131 filers reported holding MIRATI THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.6%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$494,537
+98.9%
11,353
+65.0%
0.00%
+100.0%
Q2 2023$248,611
+13.3%
6,881
+16.6%
0.00%0.0%
Q1 2023$219,362
-17.9%
5,9000.0%0.00%0.0%
Q4 2022$267,329
-21.4%
5,900
+21.1%
0.00%
-50.0%
Q3 2022$340,000
+4.0%
4,8740.0%0.00%0.0%
Q2 2022$327,000
-18.5%
4,8740.0%0.00%0.0%
Q1 2022$401,000
-46.5%
4,874
-4.5%
0.00%
-50.0%
Q4 2021$749,000
+8.4%
5,104
+30.7%
0.00%0.0%
Q3 2021$691,000
+9.9%
3,905
+0.2%
0.00%
+33.3%
Q2 2021$629,000
-10.5%
3,896
-5.1%
0.00%
-25.0%
Q1 2021$703,000
-9.4%
4,106
+16.2%
0.00%
-20.0%
Q4 2020$776,000
+42.1%
3,534
+7.5%
0.01%
+25.0%
Q3 2020$546,000
+45.6%
3,2870.0%0.00%
+33.3%
Q2 2020$375,000
+130.1%
3,287
+55.4%
0.00%
+50.0%
Q1 2020$163,000
-34.5%
2,115
+9.4%
0.00%0.0%
Q4 2019$249,000
+124.3%
1,933
+35.9%
0.00%
+100.0%
Q3 2019$111,000
-24.0%
1,4220.0%0.00%0.0%
Q2 2019$146,000
+67.8%
1,422
+19.8%
0.00%0.0%
Q1 2019$87,000
+22.5%
1,187
-29.1%
0.00%0.0%
Q4 2018$71,000
-10.1%
1,6740.0%0.00%0.0%
Q3 2018$79,000
-4.8%
1,6740.0%0.00%0.0%
Q2 2018$83,000
+4050.0%
1,674
+358.6%
0.00%
Q3 2016$2,0000.0%3650.0%0.00%
Q2 2016$2,000
-75.0%
3650.0%0.00%
Q1 2016$8,000
-33.3%
3650.0%0.00%
Q4 2015$12,0003650.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,000,000$31,470,0008.67%
Baker Brothers Advisors 2,805,074$88,276,0000.77%
Broadfin Capital, LLC 359,661$11,319,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 397,660$12,514,0000.42%
Boulegeris Investments, Inc. 17,415$548,0000.39%
SPHERA FUNDS MANAGEMENT LTD. 95,000$2,990,0000.29%
Rhenman & Partners Asset Management AB 50,000$1,574,0000.19%
Integre Asset Management, LLC 23,996$755,0000.16%
Orbimed Advisors 680,500$21,415,0000.16%
EAM Investors, LLC 38,754$1,220,0000.14%
View complete list of MIRATI THERAPEUTICS INC shareholders